Actuate Therapeutics, Inc. (ACTU)

Actuate Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022
Selling, General & Admin	3.27	3.82
Research & Development	21.71	16.39
Operating Expenses	24.97	20.21
Operating Income	-24.97	-20.21
Interest Expense / Income	-0.31	-0.01
Other Expense / Income	0.08	-0.04
Pretax Income	-24.74	-20.16
Net Income	-24.74	-20.16
Free Cash Flow	-21.63	-17.79
EBITDA	-25.05	-20.17
EBIT	-25.05	-20.17

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).